Gelonghui April 25 | Yiming Pharmaceutical (002826.SZ) announced the first quarter report of 2024. The operating income during the reporting period was 160 million yuan, a year-on-year decrease of 6.42%; the net profit attributable to shareholders of the listed company was 27.8991 million yuan, a year-on-year increase. 233.58%; net profit excluding non-recurring gains and losses attributable to shareholders of listed companies was 1.77998 million yuan, a year-on-year decrease of 77.30%; basic earnings per share was 0.15 yuan.
Yiming Pharmaceutical (002826.SZ): Net profit in the first quarter was 27.8991 million yuan, a year-on-year increase of 233.58%
Gelonghui April 25 | Yiming Pharmaceutical (002826.SZ) announced the first quarter report of 2024. The operating income during the reporting period was 160 million yuan, a year-on-year decrease of 6.42%; the net profit attributable to shareholders of the listed company was 27.8991 million yuan, a year-on-year increase. 233.58%; net profit excluding non-recurring gains and losses attributable to shareholders of listed companies was 1.77998 million yuan, a year-on-year decrease of 77.30%; basic earnings per share was 0.15 yuan.
Like (0)
Sunshine Insurance (06963) will pay a final dividend of 0.18 yuan per share on July 16
Previous
April 25, 2024 8:00 pm
Jolywood\’s first single-quarter loss since 2022 terminates investment in 14 billion silicon-based projects
Next
April 25, 2024 8:00 pm